Question 1
An unresponsive patient with suspected organophosphate poisoning receives multiple doses of intravenous atropine. The nurse should evaluate which clinical parameter as the PRIMARY endpoint to titrate atropine administration?
💡 Hint
Look closely at: organophosphate poisoning · PRIMARY endpoint to titrate atropine
- A Clearing of bronchorrhea
- B Resolution of muscle fasciculations
- C Pupillary dilation
- D Elevation of heart rate
▸Show the answer — and why each of the other three is wrong
🔑 Key takeaway
Titrate atropine in organophosphate poisoning to the clearance of bronchorrhea and dry breath sounds.
A is correct.In organophosphate toxicity, massive muscarinic overstimulation produces copious tracheobronchial secretions (bronchorrhea) and severe bronchoconstriction, which represent the primary causes of asphyxiation and death. Atropine dosing must be aggressively titrated until pulmonary secretions clear and breath sounds are dry. Clearing of bronchorrhea is the true therapeutic endpoint. Pupillary dilation is unreliable because pupil size can fluctuate with autonomic instability or co-ingestions, and adequate oxygenation may occur well before full mydriasis. Resolution of muscle fasciculations is a nicotinic receptor manifestation mediated at the neuromuscular junction; atropine only targets muscarinic receptors, so pralidoxime, not atropine, addresses nicotinic symptoms. Elevation of heart rate above baseline is not the primary target, as tachycardia can occur from hypoxia or nicotinic stimulation even when the airway remains flooded with secretions. Titrating to respiratory secretions ensures oxygenation and prevents asphyxia.